Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus

被引：0
|
作者：
Ben-Gal, Y
Moshkovitz, Y
Nesher, N
Braunstein, R
Handler, A
Zivi, E
Herz, I
Mohr, R
机构：
[1] Assuta Med Ctr, Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[3] Assuta Med Cntr, Tel Aviv, Israel
[4] Hasassah Hebrew Univ Hosp, Jerusalem, Israel
[5] Assuta Med Ctr, Tel Aviv, Israel
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3085
引用
收藏
页码：U717 / U718
页数：2
相关论文
共 50 条
  • [21] Drug-eluting stents versus surgery
    Atallah, Alvaro Nagib
    [J]. SAO PAULO MEDICAL JOURNAL, 2008, 126 (03): : 143 - 144
  • [22] Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis
    Torguson, Rebecca
    Sabate, Manel
    Deible, Regina
    Smith, Kimberly
    Chu, William W.
    Kent, Kenneth M.
    Pichard, Augusto D.
    Suddath, William O.
    Satler, Lowell F.
    Waksman, Ron
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (10): : 1340 - 1344
  • [23] Meta-Analysis Comparison (Nine Trials) of Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in Patients With Diabetes Mellitus
    Patti, Giuseppe
    Nusca, Annunziata
    Di Sciascio, Germano
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (10): : 1328 - 1334
  • [24] Hybrid coronary revascularization in the era of drug-eluting stents
    Murphy, GJ
    Bryan, AJ
    Angelini, GD
    [J]. ANNALS OF THORACIC SURGERY, 2004, 78 (05): : 1861 - 1867
  • [25] What reimbursement for coronary revascularization with drug-eluting stents?
    Tarricone R.
    Marchetti M.
    Lamotte M.
    Annemans L.
    De Jong P.
    [J]. The European Journal of Health Economics, 2004, 5 (4) : 309 - 316
  • [26] Drug-eluting stents Implications for modern coronary revascularization
    Martens, A.
    Haverich, A.
    [J]. CHIRURG, 2009, 80 (06): : 508 - +
  • [27] Drug-eluting stents versus bare metal stents
    Conti, CR
    [J]. CLINICAL CARDIOLOGY, 2003, 26 (11) : A31 - A32
  • [28] Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease
    Bausback, Yvonne
    Wittig, Tim
    Schmidt, Andrej
    Zeller, Thomas
    Bosiers, Marc
    Peeters, Patrick
    Brucks, Steffen
    Lottes, Aaron E.
    Scheinert, Dierk
    Steiner, Sabine
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (06) : 667 - 679
  • [29] Biodegradable-polymer drug-eluting stents Versus bare metal stents Versus durable-polymer drug-eluting stents in Patients With in Patients Undergoing Coronary Revascularization: a Meta-Analysis of Randomized Controlled Trials
    Zhu Jianbing
    Ge, Junbo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C169 - C170
  • [30] Culprit-lesion revascularization versus complete revascularization in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stents
    Jin, Zhe
    Rha, Seung-Woon
    Chen, Kang-yin
    Minami, Yoshiyasu
    Na, Jin Oh
    Suh, Soon Yong
    Choi, Cheol Ung
    Kim, Jin Won
    Kim, Eung Ju
    Park, Chang Gyu
    Seo, Hong Seog
    Oh, Dong Joo
    Jeong, Myung Ho
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B68 - B68
12345